Phosphate binder pill burden and cardiovascular events in patients undergoing hemodialysis
A high PB pill burden (≥9/day) is associated with increased cardiovascular risk in patients undergoing hemodialysis.
Authors
- Masahide Mizobuchi (ORCID: https://orcid.org/0000-0002-6117-8414)
- Etsuro Ogata (ORCID: https://orcid.org/0000-0002-0046-5575)
- Tomohiro Saito (ORCID: https://orcid.org/0000-0003-2303-5401)
- Kiryu Yoshida (ORCID: https://orcid.org/0000-0002-2293-0132)
- Fumihiko Koiwa (ORCID: https://orcid.org/0000-0003-3832-701X)
- Noriyuki Kato (ORCID: https://orcid.org/0000-0001-7393-6019)
- Hirokazu Honda (ORCID: https://orcid.org/0000-0002-5634-6145)
- Toshiaki Takezaki (ORCID: https://orcid.org/0000-0002-5725-6213)
- Tadashi Kato (ORCID: https://orcid.org/0000-0002-7491-9701)
Institutions
- SHOWA Medical University (JP)
- SHOWA Medical University Northern Yokohama Hospital (JP)
- SHOWA Medical University Fujigaoka Hospital (JP)
Publication Details
- Journal
- Therapeutic Apheresis and Dialysis
- Published
- 2025-03-06
- DOI
- https://doi.org/10.1111/1744-9987.70004
- Citations
- 3
- Primary Topic
- Parathyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 4.29